Small clinics deserve hospital-grade operations.
Lemoa exists for the clinics left underserved by enterprise health technology.
Give a doctor in Guwahati the same operational capability as a corporate hospital in Mumbai or Bengaluru — through the phone she already owns, in the language her patients actually speak.
From the Indian Navy and ICAR to building startups and scaling and exiting Travysys, Manoj kept encountering systems that failed the people they were meant to serve. Then came dinner with three doctor friends. Different practices. The same operational problems.
Lemoa exists for the clinics left underserved by enterprise health technology.
An AI operating system behind clinics and hospitals, connecting patients, doctors and operations as seamlessly as payment rails connect commerce.
Paying hospitals on Triage & Engagement, measured revenue recovery and no-show reduction, and readiness to expand into Coding & Revenue Cycle.
Smaller practices manage patient conversations, appointments, records and billing across disconnected tools. Each handoff creates work for staff — and another opportunity for a patient or payment to fall through.
Manual intake, scheduling and reminders leave staff chasing conversations and patients missing appointments.
Consequence: unused appointment capacity and fragmented access.
Record-keeping and repeated documentation take attention away from the patient in front of the doctor.
Consequence: less clinical time and gaps in the record.
Coding gaps, claim rework and inconsistent follow-up create avoidable work long after the consultation ends.
Consequence: delayed collections and patients lost to follow-up.
The supplied PDF cites 40% administrative time and 11% rejected claims without underlying citations. Its 30% no-show figure is a model assumption, not a measured Lemoa result. These are not presented here as verified outcomes.
Lemoa brings multilingual intake, appointment coordination and follow-up into the channels clinics and patients already use. The current entry product is Triage, Follow-up & Engagement.
The platform then extends into clinician-reviewed documentation and revenue-cycle workflows — connecting the conversation to the record, the claim and the next patient action.
Faster responses. More completed appointments. Better follow-up completion. Less repetitive staff work. These are the pilot measures to prove, not results already claimed.
The entry product earns adoption at reception and in patient follow-up. Each planned module then extends the same encounter into documentation, revenue operations and clinical support.
For reception and operations: multilingual intake, appointments, reminders and patient follow-up.
For billing teams: identify documentation gaps, suggest codes for review and support claim workflows.
For clinicians: draft structured notes from conversations, with review before final records.
Clinical support that requires validation and product-specific regulatory review before deployment.
Bengaluru pilots on Triage, Follow-up & Engagement. The Purpose brief describes this cohort as non-revenue: MRR ₹0.
Future modules, interoperability and ROI gains are a development and measurement plan, not established product outcomes.
The Purpose brief lists five clinic pilots in several sections but three clinic or hospital pilots elsewhere; the PDF lists three. The count is omitted pending reconciliation. No paid-customer count is asserted.
Sell first to doctors’ chambers, owner-led clinics and small hospitals in Bengaluru. The buyer is the doctor-owner or administrator who sees the operational and revenue pain directly.
Target platform workflow: Intake → Visit → Review → RCM → Track → Engage. Triage and engagement are the current entry points; documentation and revenue-cycle steps expand as modules launch.
Capture symptoms and patient intent in the patient’s language.
Carry intake context into the clinician’s consultation.
Clinician reviews and approves drafted clinical records.
Billing team reviews suggested codes and claim documentation.
Follow claim status, collections and operational outcomes.
Coordinate follow-ups, reminders and the next patient action.
The moat is operational, not just model quality: meet clinics where they are, learn the workflow, and compound context across the network.
WhatsApp, voice and regional languages lower the adoption barrier for patients and staff.
Configurable from reception to billing, with a wedge that creates measurable operational proof.
LemoaID and outcome data create more useful context as the clinic footprint expands.
Subscription revenue starts with the operating wedge. Performance-linked RCM revenue follows when the product is live and claims outcomes are measurable.
per month + GST
For focused clinic workflows.
per month + GST
For multi-workflow practices.
per month + GST
For hospitals and deeper operations.
RCM success fee after the module is live, plus custom plans.
Pre-revenue pilot cohort · MRR ₹0 · beta margins are not meaningful.
Paid conversion plus measured lifts in response time, appointment conversion, follow-up completion and staff productivity.
Lemoa does not need to win the whole market on day one. It needs to become indispensable to the first cohort, then let references and workflow depth travel.
small clinics form the long-term operating base. Most still manage triage, scheduling, billing and follow-up manually.
Geography sequence: Bengaluru → South India Tier-1/2 → pan-India. Market sizing is directional in the supplied materials and should be formalized as sales data compounds.
The first Purpose variant sets the operating sequence: prove Triage & Engagement, build Coding & Revenue Cycle, then extend into Ambient Documentation. These are quarterly targets, not achieved milestones.
5–10 hospitals live on Triage & Engagement. Establish the baseline for revenue recovery and no-shows.
Expand to 15–20 hospitals, measure ROI and begin the Coding & Revenue Cycle build.
Launch with existing hospitals and start building Ambient Documentation.
Go live across the hospital base and pursue a seed raise on proven metrics.
Healthcare infrastructure has to earn permission at every step. Lemoa’s expansion path keeps human review, consent and accountability in the product design.
Privacy, consent, role-based access, encryption, audit trails and retention controls are being implemented subject to legal review.
Support the clinician and staff; do not present autonomous diagnosis or final clinical decisions.
High-risk flags, review paths, liability caps and hospital-owned final decisions before higher-risk use.
ABDM, FHIR and NHCX interoperability are roadmap capabilities; clinical validation and CDSCO assessment precede higher-risk claims.
Proposed at a $3M pre-money valuation for an 18-month operating plan covering product, paid-conversion and hospital-expansion proof.
Manoj BoraFounder & CEO
AshutoshCo-founder & CTO
Dr GargiClinical & strategy
Dr LakeeClinical advisor
Dr KangkanaClinical advisorProduct / AI / cloud · sales & BD · operations / compliance · clinical validation · founder/admin · contingency/security.